Secretion of organic anions by hepatocytes: Involvement of homologues of the multidrug resistance protein

Seminars in Liver Disease

Volumn 16, Issue 2, 1996, Pages 211-220

  Müller, Michael ^a,b   Roelofsen, Han ^a   Jansen, Peter L M ^a  

^a University Hospital Croningen   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ABC superfamily; ATP dependent transport; glutathione; mutant rats; regulation

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; GLUTATHIONE; GLYCOPROTEIN P;

ACTIVE TRANSPORT; ANIMAL CELL; ANION TRANSPORT; GENE DELETION; INTRAHEPATIC BILE DUCT; LIVER CELL; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; REVIEW; TRANSPORT KINETICS;

EID: 0029937429     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007233     Document Type: Review

References (137)

1. Bossuyt X, Müller M, Hagenbuch B, Meier PJ: Polyspecific steroid and drug clearance by an organic anion transporter of mammalian liver. J Pharmacol Exp Ther 276:891-6, 1996.
2. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al: Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109:1274-82, 1995.
3. Shi XY, Bai S, Ford AC, et al: Stable inducible expression of a functional rat liver organic anion transport protein in HeLa cells. J Biol Chem 270:25591-5, 1995.
4. Jacquemin E, Hagenbuch B, Stieger B, et al: Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc Natl Acad Sci USA 91:133-7, 1994.
5. Boyer JL, Hagenbuch B, Ananthanarayanan M, et al: Phylogenic and ontogenic expression of hepatocellular bile acid transport. Proc Natl Acad Sci USA 90:435-8, 1993.
6. + bile acid cotransporter. J Clin Invest 93:1326-31, 1994.
7. Vore M: Canalicular transport - Discovery of ATP-dependent mechanisms. Toxicol Appl Pharmacol 118:2-7, 1993.
8. Gatmaitan Z, Arias IM: ATP-dependent transport systems in the canalicular membrane of the hepatocyte. Physiol Rev 75:261-75, 1995.
9. Arias IM, Che M, Gatmaitan Z, et al: The biology of the bile canaliculus, 1993. Hepatology 17:318-29, 1993.
10. Oude Elferink RPJ, Meijer DKF, Kuipers F, et al: Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Bba-Rev Biomembranes 1241:215-68, 1995.
11. Silverman JA, Thorgeirsson SS: Regulation and function of the multidrug resistance genes in liver. Prog Liver Dis 13:101-23, 1995.
12. Leveille-Webster CR, Arias IM: The biology of the p-glycoproteins. J Membr Biol 143:89-102, 1995.
13. Higgins CF: ABC transporters-from microorganisms to man. Annu Rev Cell Biol 8:67-113, 1992.
14. Fath MJ, Kolter R: ABC transporters: Bacterial exporters. Microbiol Rev 57:995-1017, 1993.
15. Doige CA, Ames GF-L: ATP-dependent transport systems in bacteria and humans: Relevance to cystic fibrosis and multidrug resistance. Annu Rev Microbiol 47:291-319, 1993.
16. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427, 1993.
17. Borst P, Schinkel AH, Smit JJM, et al: Classical and novel forms of multidrug resistance and the physiological functions of p-glycoproteins in mammals. Pharmacol Ther 60:289-99, 1993.
18. Smit JJM, Schinkel AH, Oude Elferink RPJ, et al: Homogenous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451-62, 1993.
19. Buschman E, Arceci RJ, Croop JM, et al: mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J Biol Chem 267:18093-9, 1992.
20. Oude Elferink RPJ, Ottenhoff R, Vanwijland M, et al: Regulation of biliary lipid secretion by mdr2 p-glycoprotein in the mouse. J Clin Invest 95:31-8, 1995.
21. Ruetz S, Gros P: Enhancement of mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate - Implications for hepatic bile formation. J Biol Chem 270:25388-95, 1995.
22. Ruetz S, Gros P: Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell 77:1071-81, 1994.
23. Jansen PLM, Groothuis GMM, Peters WHM, Meijer DKF: Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary conjugated hyperbilirubinemia. Hepatology 7:71-6, 1987.
24. Huber M, Guhlmann A, Jansen PLM, Keppler D: Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology 7:224-8, 1987.
25. Jansen PLM, Peters WHM, Lamers WH: Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 5:573-9, 1985.
26. Adachi Y, Kobayashi H, Shouji M, et al: Functional integrity of hepatocyte canalicular membrane transport of taurocholate and bilirubin diglucuronide in eisai-hyperbilirubinuria rats. Life Sci 52:777-84, 1993.
27. Fernández-Checa JC, Takikawa H, Horie T, et al: Canalicular transport of reduced glutathione in normal and mutant eisai hyperbilirubinemic rats. J Biol Chem 267:1667-73, 1992.
28. - rats. In: Tavoloni N, Berk PD (eds): Hepatic transport and bile secretion: Physiology and pathophysiology. New York, Raven Press, 1993, pp 721-31.
29. Kuipers F, Enserink M, Havinga R, et al: Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat. J Clin Invest 81:1593-9, 1988.
30. Kuipers F, Radominska A, Zimniak P, et al: Defective biliary secretion of bile acid 3-O-glucuromdes in rats with hereditary conjugated hyperbilirubinemia. J Lipid Res 30:1835-45, 1989.
31. Oude Elferink RPJ, Jansen PLM: The role of the canalicular multispecific organic anion transporter in the disposal of endoand xenobiotics. Pharmacol Ther 64:77-97, 1994.
32. Kurisu H, Kamiska K, Koyo T, et al: Organic anion transport study in mutant rats with autosomal recessive conjugated hyperbilirubinemia. Life Sci 49:1003-11, 1991.
33. Takikawa H, Sano N, Narita T, et al: Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat. Hepatology 14:352-60, 1991.
34. -) with inherited conjugated hyperbilirubinemia. J Clin Invest 90:2130-5, 1992.
35. -) rats with conjugated hyperbilirubinemia. Proc Natl Acad Sci USA 87:3557-61, 1990.
36. Nishida T, Hardenbrook C, Gatmaitan Z, Arias IM: ATP-dependent organic anion transport system in normal and TR-rat liver canalicular membranes Am J Physiol 262:G629-35, 1992.
37. Ishikawa T, Müller M, Klünemann C, et al: ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membranes. J Biol Chem 265:19279-86, 1990.
38. - rats with a hepatobiliary secretion defect. Am J Physiol 265:G445-52, 1993.
39. Sathirakul K, Suzuki H, Yamada T, et al: Multiple transport systems for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 268:65-73, 1994.
40. Shimamura H, Suzuki H, Hanano M, et al: Multiple systems for the biliary excretion of organic anions in rats: Liquiritigenm conjugates as model compounds. J Pharmacol Exp Ther 271:370-8, 1994.
41. Ballatori N, Truong AT: Multiple canalicular transport mechanisms for glutathione S-conjugates. Transport on both ATP- and voltage-dependent carriers. J Biol Chem 270:3594-3601, 1995.
42. Nathanson MH, Boyer JL: Mechanisms and regulation of bile secretion. Hepatology 14:551-66, 1991
43. 1, cell volume, and bile secretion. Annu Rev Physiol 54:415-38, 1992.
44. Oude Elferink RPJ, Ottenhoff R, Liefting W, et al: Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. J Clin Invest 84:476-83, 1989.
45. Roelofsen H, Bakker CTM, Schoemaker B, et al: Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes. Hepatology 21:1649-57, 1995.
46. Franson TR, Hierholtzer WJ, LaBrecque DR: Frequency and characteristics of hyperbilirubinemia associated with bacteremia. Rev Infect Dis 7:1-9, 1985.
47. Pirovino M, Meister F, Rubli E, Karlaganis G: Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection. Gastroenterology 96:1589-95, 1989.
48. Roelofsen H, Vanderveere CN, Ottenhoff R, et al: Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 107:1075-84, 1994.
49. Whiting JF, Green RM, Rosenbluth AB, Gollan JL: Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology 22:1273-8, 1995.
50. Roelofsen H, Schoemaker B, Bakker C, et al: Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol-Gastroimest L 32:G427-34, 1995.
51. Wettstein M, Noe B, Haussinger D: Metabolism of cysteinyl leukotrienes in the perfused rat liver: The influence of endotoxin pretreatment and the cellular hydration state. Hepatology 22:235-40, 1995.
52. Roelofsen H, Ottenhoff R, Oude Elferink RPJ, Jansen PLM: Hepatocanalicular organic-anion transport is regulated by protein kinase C. Biochem J 278:637-41, 1991.
53. Germann UA, Chambers TC, Arabudkar SV, et al: Effects of phosphorylation of p-glycoprotein on multidrug resistance. J Bioenerg Biomemb 27:53-61, 1995.
54. Morris AP, Firzzell RA: Vesicle targeting and ion secretion in epithelial cells: Implications for cystic fibrosis. Annu Rev Physiol 56:371-97, 1994.
55. Riordan JR: The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 55:609-30, 1993.
56. Bradbury NA, Bridges RJ: Role of membrane trafficking in plasma membrane solute transport. Am J Physiol 267:C1-24, 1994.
57. Forte JG: Regulation of secretion and absorption by recruitment and recycling of primary transport proteins. Gastroenterology 109:1706-9, 1995.
58. 2+ on exocytosis in the isolated perfused rat liver. Hepatology 20:1032-40, 1994.
59. Roelofsen H, Soroka CJ, Boyer JL: Cyclic AMP stimulates sorting of the canalicular multispecific organic anion transporter into the transcytotic bile secretory pathway in hepatocyte couplets. Hepatology 20:174A, 1994.
60. Oude Elferink RPJ, Roelofsen H, Bakker C, et al: In: Keppler D, Jungermann K (eds): Intracellular vesicles and the transport of organic anions. Dordrecht, Kluwer Academic Publishers, 1994, pp 117-126.
61. Oude Elferink RPJ, Bakker CTM, Roelofsen H, et al: Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter. Hepatology 17:434-44, 1993.
62. Kothe MJC, Bakker CTM, de Haan J, et al: Canahcular organic anion transport after bile duct ligation and reconstruction in the rat. Hepatology 18:138A, 1993.
63. - exchanger in rat hepatocytes. Proc Natl Acad Sci USA 91.792-6, 1994.
64. Boyer JL, Soroka CJ: Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology 109:1600-11, 1995.
65. Hayakawa T, Bruck R, Ng OC, Boyer JL: DBcAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am J Physiol 259:G727-35, 1990.
66. Hansen SH, Casanova JE: GSa stimulates transcytosis and apical secretion in MDCK cells through cAMP and protein kinase A. J Cell Biol 126:677-87, 1994.
67. Pimplikar SW, Simons K: Activators of protein kinase A stimulate apical but not basolateral transport in epithelial Madin-Darby canine kidney cells. J Biol Chem 269:19054-9, 1994.
68. Gatmaitan ZC, Nies AT, Arias IM: Selectively increased translocation of apical membrane proteins by taurocholate and cAMP. Hepatology 22:322A, 1995.
69. Cole SPC, Bhardwaj G, Geriach JH, et al: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258:1650-4, 1992.
70. Krishnamachary N, Ma L, Zheng L, et al: Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin. Oncol Res 6:119-27, 1994.
71. Zaman GJR, Versantvoort CHM, Smit JJM, et al: Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53.1747-50, 1993.
72. Eijdems EWHM, Dehaas M, Cocomartin JM, et al: Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon. Int J Cancer 60:676-84, 1995.
73. Abe T, Hasegawa S, Taniguchi K, et al: Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer 58.860-4, 1994.
74. Barrand MA, Heppellparton AC, Wright KA, et al: A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Nat Cancer lost 86:110-7, 1994.
75. Slapak CA, Fracasso PM, Martell RL, et al: Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Res 54;5607-13, 1994.
76. Slapak CA, Mizunuma N, Kufe DW: Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood 84:3113-21, 1994.
77. Slovak ML, Ho JP, Bhardwaj G, et al: Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res 53:3221-5, 1993.
78. Beck J, Niethammer D, Gekeler V: High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in b-cell chronic lymphocytic leukaemias. Cancer Lett 86:135-42, 1994.
79. Abbaszadegan MR, Futscher BW, Klimecki WT, et al: Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 54:4676-9, 1994.
80. Burger H, Nooter K, Zaman GJR, et al. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 8:990-7, 1994.
81. Burger H, Nooter K, Sonneveld P, et al: High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukemia. Br J Cancer 88:348-56, 1994.
82. Hart SM, Ganeshaguru K, Hoffbrand AV, et al: Expression of the multidrug resistance-associated protein (MRP) in acute leukaemia. Leukemia 8:2163-8, 1994.
83. Almquist KC, Loe DW, Hipfner DR, et al: Characterization of the m(r) 190,000 multidrug resistance protein (MRP) in drugselected and transfected human tumor cells. Cancer Res 55:102-10, 1995.
84. Ma L, Krishnamachary N, Center MS: Phosphorylation of the multidrug resistance associated protein gene encoded protein p190. Biochemistry 34:3338-43, 1995.
85. Cole SPC, Sparks KE, Fraser K, et al: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-10, 1994.
86. Grant CE, Valdimarsson G, Hipfner DR, et al: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357-61, 1994.
87. Zaman GJR, Flens MJ, Vanleusden MR, et al: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822-6, 1994.
88. Kruh GD, Chan A, Myers K, et al: Expression complementary DNA library transfer establishes MRP as a multidrug resistance gene. Cancer Res 54:1649-52, 1994.
89. Versantvoort CHM, Broxterman HJ, Pinedo HM, et al: Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 52:17-23, 1992.
90. Szczypka MS, Wemmie JA, Moye-Rowley WS, Thiele DJ: A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. J Biol Chem 269:22853-7, 1994.
91. Papadopoulou B, Roy G, Dey S, et al: Contribution of the Leishmania P-glycoprotein-related gene 1 tpgpA to oxyanion resistance J Biol Chem 269:11980-6, 1994.
92. Zaman GJR, Lankelma J, van Tellingen O, et al: Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc Natl Acad Sci USA 92:7690-4, 1995.
93. Leier I, Jedlitschky G, Buchholz U, et al: The MRP gene encodes an ATP-dependent export pump for leukotriene C4, and structurally related conjugates. J Biol Chem 269:27807-10, 1994.
94. Müller M, Meijer C, Zaman GJR. et al: Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport, Proc Natl Acad Sci USA 91:13033-7, 1994.
95. Müller M, Roelofsen H, van der Deen M, et al: The function of the multidrug resistance protein. In: Wehner F, Petzinger E (eds): Cell biology and molecular basis of liver transport. Dortmund, Projekt Verlag, 1995, pp 154-60.
96. Feller N, Broxterman HJ, Wahrer DCR, Pinedo HM: ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): No inhibition by intracellular glutathione depletion. FEES Lett 368:385-8, 1995.
97. Berhane K, Widersten M, Engstrom A, et al: Detoxication of base propenals and other alpha,beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci USA 91:1480-4, 1994.
98. Dröge W, Schulze-Osthoff K, Mihm S, et al: Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 8:1131-8, 1994.
99. Ishikawa T: The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17:463-8, 1992.
100. Ishikawa T: Glutathione S-conjugate export pump. In: Tew KD, Pickett CB, Mantle TJ, et al (eds): Structure and function of glutathione S-transferases. Boca Raton, CRC Press, 1993, pp 211-21.
101. Deleve LD, Kaplowitz N: Importance and regulation of hepatic glutathione. Semin Liver Dis 10:251-66, 1990.
102. Yu BP: Cellular defense against damage from reactive oxygen species. Physiol Rev 74:139-62, 1994.
103. 2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles. J Biol Chem 264:17343-8, 1989.
104. Barrera G, Muraca R, Pizzimenti S, et al: Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. Biochem Biophys Res Commun 203:553-61, 1994.
105. Friguet B, Stadtman ER, Szweda LI: Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal-Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 269:21639-43, 1994.
106. Grune T, Siems WG, Zollner H, Esterbauer H: Metabolism of 4-hydroxynonenal, a cytotoxic lipid peroxidation product, in Ehrlich mouse ascites cells at different proliferation stages. Cancer Res 54:5231-5, 1994.
107. Bordow SB, Haber M, Madafiglio J, et al: Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the n-myc oncogene in childhood neuroblastoma. Cancer Res 54:5036-40, 1994.
108. Ishikawa T, Wright CD, Ishizuka H: GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation J Biol Chem 269:29085-93, 1994.
109. Gaudiano G, Resing K, Koch TH: Reaction of anthracycline antitumor drugs with reduced glutathione. Formation of aglycon conjugates. J Am Chem Soc 116:6537-44, 1994.
110. Gekeler V, Ise W, Sanders KH et al: The leukotriene LTD(4) receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 208:345-52, 1995.
111. Versantvoort CHM, Broxterman HJ, Bagrij T, et al: Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72:82-9, 1995.
112. Meister A: Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmac Ther 51:155-94, 1991.
113. Odwyer PJ, Hamilton TC, Yao KS, et al: Modulation of glutathione and related enzymes in reversal of resistance to anti-cancer drugs. Hematol Oncol Clin N Amer 9:383-96, 1995.
114. Paulusma CC, Bosma PJ, Zaman GJR, et al: Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271:1126-8, 1996.
115. Mayer R, Kartenbeck J, Büchler M, et al: Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol 131:137-50, 1995.
116. Mayer R, Kartenbeck J, Büchler M, et al: Expression and localization of the MRP-encoded conjugate export pump in human and rat liver. Hepatology 22:295A, 1995.
117. Jedlitschky G, Leier I, Buchholz U, et al: ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54:4833-6, 1994.
118. Roelofsen H, Vos T, van der Deen M, et al: Localization of the multidrug resistance protein (MRP) and P-glycoprotein (Pgp) in polarized HepG2 cells: Comparison with the distribution of transport activity. Hepatology 22:312A, 1995.
119. Olive C, Board P. Glutathione S-conjugate transport by cultured human cells. BBA-Mol Cell Res 1224:264-8, 1994.
120. Adachi Y, Kobayashi H, Kurumi Y, et al: ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 14:655-9, 1991.
121. Müller M, Ishikawa T, Berger U, et al: ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem 266:18920-6, 1991.
122. Nishida T, Gatmaitan Z, Che M, Arias IM: Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc Natl Acad Sci USA 88:6590-4, 1991.
123. Stieger B, O'Neill B, Meier PJ: ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles. Biochem J 284:67-74, 1992.
124. Wolters H, Kuipers F, Slooff MJH, Vonk RJ: Adenosine triphosphate-dependent taurocholate transport in human liver plasma membranes. J Clin Invest 90.2321-6, 1992.
125. Böhme M, Muller M, Leier I, et al: Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107:255-65, 1994.
126. Homolya L, Hollo Z, Germann UA et al: Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493-6, 1993.
127. Ihrke G, Hubbard AL: Control of vesicle traffic in hepatocytes. Prog Liver Dis 13:63-99, 1995.
128. Ishikawa T, Ali-Osman F: Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. J Biol Chem 268:20116-25, 1993.
129. Yi JR, Lu SL, Fernández-Checa JC, Kaplowitz N: Expression cloning of a rat hepatic reduced glutathione transporter with canalicular characteristics. J Clin Invest 93:1841-5, 1994.
130. Yi JR, Lu SL, Fernández-Checa JC, Kaplowitz N: Expression cloning of the cDNA for a polypeptide associated with rat hepatic sinusoidal reduced glutathione transport: Characteristics and comparison with the canalicular transporter. Proc Natl Acad Sci USA 92:1495-9, 1995.
131. + bile acid cotransport system. Proc Natl Acad Sci USA 88:10629-33, 1991.
132. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al: Functional characterization of the basolateral rat liver organic amon transporting polypeptide. Hepatology 20:411-6, 1994.
133. Meijer DKF, Mol WEM, Müller M, Kurz G: Carrier mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokin Biopharm 18:35-70, 1990.
134. Müller M, Mayer R, Hero U, Keppler D: ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr1 p-glycoprotein. FEES Lett 343:168-72, 1994.
135. Müller M, Mittenbühler K, Mayer R, et al: ATP-dependent transport of amphiphilic cations across the canalicular membrane mediated by P-glycoprotein. In: Keppler D, Jungermann K (eds): Transport in the liver. Dordrecht, Kluwer Academic Publishers, 1994, pp 156-65.
136. Grundemann D, Gorboulev V, Gambaryan S, et al: Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549-52, 1994.
137. Childs S, Yeh RL, Georges E, Ling V: Identification of a sister gene to p-glycoprotein. Cancer Res 55:2029-34, 1995